Current Edition

News

Theresa May unveils £75m prostate cancer research fund

Prime Minister Theresa May has announced an investment of £75 million into research targeting earlier diagnosis and better treatment for men with prostate cance...
Continue Reading →
News

Phillips-Medisize Announces Expansion of Significant Medical Customer for Molex Little Rock Facility

Phillips-Medisize, a Molex company, announces the expansion of a significant medical customer for the Molex Little Rock facility. The long-time customer is a leader ...
Continue Reading →
News

Single blood test screens for eight cancer types

Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the ...
Continue Reading →
News

Almac Discovery publishes USP7 inhibitors from UbiPlexTM Platform

Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, has today published its find...
Continue Reading →
News

BIOCAD launches the new manufacturing site in North Africa

Russian biotechnology company BIOCAD and Moroccan pharmaceutical company Sothema Labs announced the launch of medicines derived using the technology provided by the ...
Continue Reading →
News

CRUK Manchester Institute to set up major base at Alderley Park

Alderley Park’s position as a key asset in the North of England has been underlined by confirmation that it is to be the interim home for the Cancer Research UK Manc...
Continue Reading →
News

Genmab Achieves USD 50 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen

Genmab has announced that it has achieved a USD 50 million sales volume milestone in its DARZALEX® (daratumumab) collaboration with Janssen Biotech, Inc.  The m...
Continue Reading →
News

Locus Biosciences raises $19 million series A for CRISPR-Cas3 Antimicrobials

Locus Biosciences has closed $19 million in Series A funding led by venture capital firm ARTIS Ventures with additional financing from notable institutional investor...
Continue Reading →